Printer Friendly
The Free Library
23,389,518 articles and books


Protalix BioTherapeutics to Present at Three International Healthcare Conferences.

CARMIEL, Israel -- Protalix BioTherapeutics, Inc. (Amex: PLX), today announced that Dr. David Aviezer, the Company's President and Chief Executive Officer, will be presenting at the 7th National Life Science Week, Biomed Conference and at the 2008 Bio International Convention. Additionally, the Company will be giving a presentation on its ongoing clinical development program for the treatment of Gaucher Disease at the 8th European Working Group on Gaucher Disease Meeting.

The conference schedule is as follows:
[TABLE OMITTED]


About Protalix BioTherapeutics

Protalix is a biopharmaceutical company. Its goal is to become a fully integrated biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins to be expressed through its proprietary plant cell based expression system. Protalix's ProCellEx(TM) presents a proprietary method for the expression of recombinant proteins that Protalix believes is safe and scalable and will allow for the cost-effective, industrial-scale production of recombinant therapeutic proteins. Protalix is enrolling and treating patients in its pivotal phase III clinical trial in Israel, the United States and other locations for its lead product candidate, prGCD, for its enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder in humans, and has reached an agreement with the United States Food and Drug Administration on the final design of the pivotal phase III clinical trial through the FDA's Special Protocol Assessment (SPA) process. Protalix is also advancing additional recombinant biopharmaceutical drug development programs.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Conference news
Date:May 23, 2008
Words:232
Previous Article:Media Breakaway, LLC Announces Next Community Involvement Initiative.
Next Article:Safe Riding Tips from the ATV Safety Institute as Summer Riding Season Begins this Holiday Weekend.
Topics:



Related Articles
ORTHODONTIX/PROTALIX SIGN MERGER AGREEMENT.
GTC Biotherapeutics to Webcast Corporate Presentation at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference.
Dyax to Present at the Lehman Brothers Global Healthcare Conference.
Talecris Biotherapeutics Debuts CIDPinfo.com for Neurologists and Healthcare Providers.
Dyax Corp. To Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference.
GTC Biotherapeutics to Webcast Corporate Presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.
Dyax Corp. To Present at the Credit Suisse Healthcare Conference.
Dyax Corp. to Present at the JPMorgan Healthcare Conference.
Dyax Corp. to Present at the Susquehanna Healthcare Conference.
GTC Biotherapeutics to Webcast Corporate Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters